维普期刊资源整合服务平台（V6.5）

26篇 您的检索式：作者名="Mustea"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Vascular endothelial growth factor gene polymorphisms are associated with prognosis in Ovarian cancer显示文摘	Hefler LA Mustea A Konsgen D	2007	Clin Cancer Res2007，13，3：	1
2	Polymorphism of IL-1 receptor antagonist gene:role in cancer显示文摘	Sehouli J Mustea A Konsgen D	2002	Anticancer Res2002，22，6：	1
3	Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer显示文摘	Mustea A Pirvulescu C Konsgen D	2008	Cytokine2008，42，1：	1
4	Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer显示文摘	Hefler LA Mustea A KSnsgen D	2007	Clin Cancer Res2007，13，：	1
5	Interleukin 1 receptor antagonist(IL-1 RA) Polymorphism in women with cervical cancer 显示文摘	Mustea A Sehouli J Konsgen D	2003	Anticancer Res2003，23，2：	1
6	Systematic analysis and validation of differential gene expression in ovarian serous adenocarcinomas and normal ovary显示文摘	Dirk Bauerschlag Karen Br?utigam Roland Moll Jalid Sehouli Alexander Mustea Darius Salehin Maryla Krajewska John C. Reed Nicolai Maass Garret M. Hampton Ivo Meinhold-Heerlein	2013	Journal of Cancer Research and Clinical Oncology2013，，2：	1
7	Weekly paclitaxel and carboplatin (PC-W)for patients with primary advanced ovarian cancer:results of a multicenter phase-II study of the NOGGO 显示文摘	Sehouli J Stengel D Mustea A	2008	Cancer Chemother Pharmacol2008，61，：	1
8	Expression of estrogen receptor-related receptors, a subfamily of orphan nuclear receptors, as new tumor biomarkers in ovarian cancer cells显示文摘	Pengming Sun Jalid Sehouli Carsten Denkert Alexander Mustea Dominique K?nsgen Ines Koch Lihui Wei Werner Lichtenegger	2005	Journal of Molecular Medicine2005，，6：	1
9	Adjuvant s- equential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, muhicenter phase-II study of the NOGGO (North-Eastern German Society of Gynaecological Oncology) 显示文摘	MUSTEA A KOENSGEN D BELAU A	2013	Cancer Chemother Pharmacol2013，72，5：	1
10	Optimization of medium components in vitamin B12 biosynthesis 显示文摘	Roman R V Iluc E Mustea A etal	2001	Roum Biotechnol Lett2001，6，：	1
11	Interleukin-1 receptor antagonist gene polymorphism in epithelial ovarian cancer 显示文摘	Sehouli J Mustea A Koensgen D	2003	Cancer Epidemiol Biomarkers Prey2003，12，11：	1
12	Granulosa cell tumor of the Ovary:10 years follow-up data of 65 patients显示文摘	Sehouli J Drescher FS Mustea A	2004	Anticancer Res2004，24，2：	1
13	Optimization of Medium Components in Vitamin B12 Biosynthesis显示文摘	Roman RV Iuc E Mustea A	2001	Roum Biotechnol Lett2001，6，4：	1
14	Granulosa cell tumor of the Ovary: 10 years follow - up data of 65 patients 显示文摘	Sehouli J Drescher FS Mustea A	2004	Anticancer Res2004，24，2：	1
15	Perioperative morbidity and rate of upstaging after laparoscopic staging for patients with locally advanced cervical cancer:results of a prospective randomized trial显示文摘	Kohler C Mustea A Marnitz S	2015	Am J Obstet Gynecol2015，213，：	1
16	Polymorphism of IL-la,IL-1βand IL-10 in patients with advanced ovarian cancer:Results of a prospective study with 147 patients显示文摘	Ioans Braicu E Mustea A Toliat MR	2007	Gynecol Oncol2007，104，3：	1
17	Granulosa cell tumor of the Ovary:10 years follow-up data of 65 patients显示文摘	Sehouli J Dreacher FS Mustea A	2004	Anticancer Res2004，24，2：	1
18	Weekly paclitaxel and carbopla-tin( PC-W) for patients with primary advanced ovarian cancer: resultsof a multicenter phase-II study of the NOGGO显示文摘	Sehouli J Stengel D Mustea A	2008	Cancer ChemotherPharmacol2008，61，2：	1
19	Optimization of Medium Components in Vitamin B12 Biosynthesis 显示文摘	Roman RV Iluc E Mustea A	2001	Roum Biotechnol Lett2001，6，：	1
20	Granulosa cell tumor of the ovary: 10 years follow-up data of 65 patients显示文摘	Sehouli J Drescher FS Mustea A	2004	Anticancer Res2004，24，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示